Aptiv Delivering Production-Ready Edge AI with Long-Term Support with NVIDIA Skylo and Inmarsat work together to enable world’s first commercial narrowband IoT over satellite solution
Innovative start-up to connect machines in remote areas, across oceans, and in dense metropolitan areas…
Jeroen Weites leaves his position as the Chairperson of the Management Board of JSC Olainfarm
The Supervisory Council of JSC Olainfarm has received an application from the Chairperson of the…
AB Science is providing a summary of the live webcast held on June 3, 2021 following the voluntary hold in the clinical studies of masitinib
PRESS RELEASE SUMMARY OF THE WEBCAST HELD ON JUNE 3, 2021 FOLLOWING THE VOLUNTARY HOLD…
Pacific Biosciences Welcomes Neil Ward to Its Leadership Team as Vice President and General Manager for Europe, Middle East, and Africa
Industry Veteran Will Lead PacBio’s Commercial Footprint Across the Region MENLO PARK, Calif., June 08,…
Polyphor Hosting Key Opinion Leader Roundtable on Covid-19: The Need for Novel Therapies for Severe Infections and the Potential Role of Balixafortide, a Selective CXCR4 Antagonist
Webinar Roundtable Being Held Thursday, June 10th @ 8amET/2pmCET ALLSCHWIL, Switzerland, June 08, 2021 (GLOBE…
OXURION Completes Patient Enrollment for Part A of Phase 2 Study Evaluating THR-149 for Treatment of Diabetic Macular Edema (DME)
THR-149 is a potent plasma kallikrein inhibitor for the treatment of DME in the roughly…
Roche obtains CE mark for the SARS-CoV-2 Antigen Self Test Nasal allowing for rapid self testing of COVID-19 at home
The SARS-CoV-2 Antigen Self Test Nasal enables individuals to quickly and conveniently test themselves for…
Orion and the Blood Service launch collaboration to develop new CAR T-cell cancer therapy
ORION CORPORATION PRESS RELEASE 8 JUNE 2021 AT 8.00 a.m….
Avicanna Provides Bi-Weekly Update On Status Of Management Cease Trade Order
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
HOOKIPA Phase 1 HB-200 data show unprecedented T cell response, favorable tolerability, and preliminary efficacy as monotherapy for advanced HPV16+ cancers
Novel arenaviral therapeutic HB-200 generates outstanding tumor antigen-specific CD8+ T cell responses (average of 6…
Zymergen to Present at Goldman Sachs Annual Global Healthcare Conference
EMERYVILLE, Calif., June 07, 2021 (GLOBE NEWSWIRE) — Biofacturing leader Zymergen today announced the company will…
Arvinas Participates in Groundbreaking Ceremony for New Space Within Downtown Crossing Development in New Haven
101 College Street Groundbreaking Ceremony Arvinas participates in a ceremonial groundbreaking for 101 College Street,…
CELSION CORPORATION ANNOUNCES ADJOURNMENT OF ANNUAL MEETING
A Quorum Has Been Achieved to Reconvene Annual Meeting on Thursday June 10, 2021 Polls…
Centessa Pharmaceuticals to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
CAMBRIDGE, Mass. and LONDON, June 07, 2021 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA)…
Design Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
CARLSBAD, Calif., June 07, 2021 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology…
Design Therapeutics Expands Board of Directors with Key Appointments
CARLSBAD, Calif., June 07, 2021 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology…
Histogen Announces $6.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
SAN DIEGO, June 07, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (Nasdaq: HSTO), a clinical-stage therapeutics…
Galapagos increases share capital through subscription right exercises
Mechelen, Belgium; 7 June 2021, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ:…
Reata Pharmaceuticals Announces Participation in The Goldman Sachs 42nd Annual Global Healthcare Conference
PLANO, Texas, June 07, 2021 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the…
Biogen and Eisai launch multiple initiatives to help patients with Alzheimer’s disease access ADUHELM™
Programs now available to support patients and families with their treatment journey Collaborations with Veterans…